MIJANOU MARRETTA-LEWIS: Open Payments
NPI 1235627142 · CENTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 23 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Lilly USA, LLC | 4 | $67 |
| Novo Nordisk Inc | 3 | $60 |
| Amgen Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Janssen Biotech, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| UCB, Inc. | 1 | $21 |
Products named: VRAYLAR, Kerendia, Ozempic, JARDIANCE, MOUNJARO, EVENITY, TREMFYA, GARDASIL 9.
Industry payments across OH — which companies pay providers there.
